Elisabetta Carini

501 total citations
11 papers, 268 citations indexed

About

Elisabetta Carini is a scholar working on Infectious Diseases, Virology and Hepatology. According to data from OpenAlex, Elisabetta Carini has authored 11 papers receiving a total of 268 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 10 papers in Virology and 3 papers in Hepatology. Recurrent topics in Elisabetta Carini's work include HIV/AIDS drug development and treatment (11 papers), HIV Research and Treatment (10 papers) and HIV/AIDS Research and Interventions (4 papers). Elisabetta Carini is often cited by papers focused on HIV/AIDS drug development and treatment (11 papers), HIV Research and Treatment (10 papers) and HIV/AIDS Research and Interventions (4 papers). Elisabetta Carini collaborates with scholars based in Italy and United States. Elisabetta Carini's co-authors include Antonella Castagna, Adriano Lazzarin, Anna Danise, Hamid Hasson, Stefano Menzo, Massimo Clementi, Laura Galli, Nicola Gianotti, Andrea Galli and Massimo Cernuschi and has published in prestigious journals such as PLoS ONE, Antimicrobial Agents and Chemotherapy and AIDS.

In The Last Decade

Elisabetta Carini

11 papers receiving 260 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elisabetta Carini Italy 7 243 226 33 33 19 11 268
Linda Harrison United States 7 253 1.0× 217 1.0× 30 0.9× 57 1.7× 13 0.7× 10 290
José M. Miró Spain 11 271 1.1× 178 0.8× 61 1.8× 94 2.8× 13 0.7× 21 310
Elisabetta Chiesa Italy 11 306 1.3× 242 1.1× 96 2.9× 63 1.9× 14 0.7× 17 351
Corine Chazallon France 6 284 1.2× 214 0.9× 79 2.4× 53 1.6× 13 0.7× 12 320
Eugénio Teófilo Portugal 9 254 1.0× 178 0.8× 63 1.9× 74 2.2× 12 0.6× 22 319
Antonella d'Arminio-Monforte Italy 10 329 1.4× 331 1.5× 55 1.7× 64 1.9× 24 1.3× 14 387
G Moyle United Kingdom 7 158 0.7× 112 0.5× 56 1.7× 35 1.1× 19 1.0× 16 194
Concepción Cepeda Spain 5 237 1.0× 162 0.7× 97 2.9× 29 0.9× 23 1.2× 5 263
Enrico Barchi Italy 7 192 0.8× 149 0.7× 37 1.1× 80 2.4× 7 0.4× 10 219
Anita Scribner United States 6 203 0.8× 156 0.7× 62 1.9× 48 1.5× 12 0.6× 7 245

Countries citing papers authored by Elisabetta Carini

Since Specialization
Citations

This map shows the geographic impact of Elisabetta Carini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabetta Carini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabetta Carini more than expected).

Fields of papers citing papers by Elisabetta Carini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabetta Carini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabetta Carini. The network helps show where Elisabetta Carini may publish in the future.

Co-authorship network of co-authors of Elisabetta Carini

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabetta Carini. A scholar is included among the top collaborators of Elisabetta Carini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabetta Carini. Elisabetta Carini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Canetti, Diana, Emanuela Messina, Elisabetta Carini, et al.. (2024). Long-term outcome in a person with pandrug-resistant HIV: the added value of a multidisciplinary approach. JAC-Antimicrobial Resistance. 6(3). dlae074–dlae074. 1 indexed citations
2.
Gianotti, Nicola, Laura Galli, Liviana Della Torre, et al.. (2021). Residual viremia in HIV-infected patients who continue a two-drug or switch to a three-drug integrase strand transfer inhibitor based regimen. AIDS. 35(9). 1513–1516. 5 indexed citations
3.
Castagna, Antonella, Camilla Muccini, Laura Galli, et al.. (2019). Analytical treatment interruption in chronic HIV-1 infection: time and magnitude of viral rebound in adults with 10 years of undetectable viral load and low HIV-DNA (APACHE study). Journal of Antimicrobial Chemotherapy. 74(7). 2039–2046. 25 indexed citations
4.
Galli, Laura, Andrea Poli, Nicola Gianotti, et al.. (2018). Long-term efficacy and safety of rilpivirine plus abacavir and lamivudine in HIV-1 infected patients with undetectable viral load. PLoS ONE. 13(2). e0191300–e0191300. 1 indexed citations
5.
Spagnuolo, Vincenzo, Laura Galli, Andrea Poli, et al.. (2017). Associations of statins and antiretroviral drugs with the onset of type 2 diabetes among HIV-1-infected patients. BMC Infectious Diseases. 17(1). 43–43. 16 indexed citations
6.
Galli, Laura, Alba Bigoloni, Simona Bossolasco, et al.. (2014). Unboosted atazanavir with lamivudine/emtricitabine for patients with long‐lasting virological suppression. Journal of the International AIDS Society. 17(4S3). 19811–19811. 2 indexed citations
7.
Castagna, Antonella, Vincenzo Spagnuolo, Laura Galli, et al.. (2014). Simplification to atazanavir/ritonavir monotherapy for HIV-1 treated individuals on virological suppression. AIDS. 28(15). 2269–2279. 16 indexed citations
8.
Nozza, Silvia, Laura Galli, Stefania Salpietro, et al.. (2008). Excellent short-term CD4 recovery with a PI- and NRTI-sparing regimen in triple-class failure HIV-infected patients: raltegravir, maraviroc, etravirine. Journal of the International AIDS Society. 11(Suppl 1). P45–P45. 6 indexed citations
9.
Castagna, Antonella, Anna Danise, Stefano Menzo, et al.. (2006). Lamivudine monotherapy in HIV-1-infected patients harbouring a lamivudine-resistant virus: a randomized pilot study (E-184V study). AIDS. 20(6). 795–803. 114 indexed citations
10.
Seminari, Elena, Laura Galli, Hamid Hasson, et al.. (2005). Higher plasma lopinavir concentrations are associated with a moderate rise in cholestasis markers in HIV-infected patients. Journal of Antimicrobial Chemotherapy. 56(4). 790–792. 13 indexed citations
11.
Menzo, Stefano, Antonella Castagna, Alessia Monachetti, et al.. (2004). Genotype and Phenotype Patterns of Human Immunodeficiency Virus Type 1 Resistance to Enfuvirtide during Long-Term Treatment. Antimicrobial Agents and Chemotherapy. 48(9). 3253–3259. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Linda Harrison Breakdown of academic impact, for papers by José M. Miró Breakdown of academic impact, for papers by Elisabetta Chiesa Breakdown of academic impact, for papers by Corine Chazallon Breakdown of academic impact, for papers by Eugénio Teófilo Breakdown of academic impact, for papers by Antonella d'Arminio-Monforte Breakdown of academic impact, for papers by G Moyle Breakdown of academic impact, for papers by Concepción Cepeda Breakdown of academic impact, for papers by Enrico Barchi Breakdown of academic impact, for papers by Anita Scribner
Rankless by CCL
2026